New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 23, 2012
13:15 EDTRIMM, WMT, BAX, ALU, MAPP, OCZOn The Fly: Closing Wrap
Stocks on Wall Street were higher during the post-holiday short session, with each of the major averages adding over 1%. Following an initial move higher in the first hour after the bell, aided by some encouraging economic data from abroad, the indices drifted higher for the remainder of the day and closed at their highs... ECONOMIC EVENTS: In the U.S., no major economic data was released, however, in Europe, separate reports showed business confidence increased in November in both Germany and France. Also, in China, HSBC's Manufacturing Purchasing Managers' Index increased to 50.4, indicating expansion... COMPANY NEWS: Wal-Mart (WMT) announced had its "best ever Black Friday events" in spite of some scattered strikes by workers and shares advanced $1.31, or 1.90%, to $70.20... Research in Motion (RIMM) shares benefited a day after National Bank raised it price target on the stock to $15 from $12. The firm said in a note to investors yesterday that RIM's new management team is executing by maintaining the BlackBerry subscriber base and U.S. listed shares rose $1.40, or 13.65%, to $11.66 in their first day of trading following the bullish write-up... Shares of Baxter (BAX) moved up $2.69, or 4.07%, to $68.81 after The Wall Street Journal said the company is in talks to buy medical-equipment maker Gambro for about $4B to round out its kidney-dialysis business... MAJOR MOVERS: Among the notable gainers were Alcatel-Lucent (ALU), up 10c, or 10.00%, to $1.10 after Bloomberg said the company is in talks with Goldman Sachs (GS) on a loan to strengthen its balance sheet, and MAP Pharmaceuticals (MAPP), up $2.60, or 20.28%, to $15.42 after the company announced that the FDA accepted its Levadex resubmission with a six-month review. Among the noteworthy losers was OCZ Technology (OCZ), which fell 3c, or 2.52%, to $1.16 following its disclosure of a SEC inquiry... INDICES: The Dow was up 172.79, or 1.35%, to 13,009.68; the Nasdaq was up 40.30, or 1.38%, to 2,966.85; and the S&P 500 was up 18.12, or 1.30%, to 1,409.15.
News For RIMM;WMT;BAX;ALU;MAPP;OCZ From The Last 14 Days
Check below for free stories on RIMM;WMT;BAX;ALU;MAPP;OCZ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 14, 2014
07:30 EDTWMTWal-Mart says saw double-digit e-commerce growth in 4 'most important' markets
Wal-Mart saw double-digit e-commerce growth from its "four most important markets," the U.S., U.K., China and Brazil, in Q1, Wal-Mart President and CEO Doug McMillon stated on the company's Q2 earnings call.
07:22 EDTWMTWal-Mart to hold a summit
2nd Annual U.S. Manufacturing Summit is being held in Denver, Colorado on August 14 at 4 pm. Webcast Link
07:10 EDTWMTWal-Mart CEO says pleased with 'solid' EPS, encouraged by e-commerce growth
Subscribe for More Information
07:07 EDTWMTWal-Mart sees Q3 EPS $1.10-$1.20, consensus $1.18
Subscribe for More Information
07:06 EDTWMTWal-Mart reports Q2 U.S. SSS flat
Subscribe for More Information
07:05 EDTWMTWal-Mart lowers FY15 EPS view to $4.90-$5.15 from $5.10-$5.45, consensus $5.15
Subscribe for More Information
07:02 EDTWMTWal-Mart reports Q2 EPS $1.21, consensus $1.21
Subscribe for More Information
August 13, 2014
15:05 EDTWMTNotable companies reporting before tomorrow's open
Subscribe for More Information
12:44 EDTWMTEarnings Preview: Wal-Mart sees Q2 EPS $1.15-$1.25, U.S. SSS flat
Subscribe for More Information
12:03 EDTWMTWal-Mart technical comments ahead of results
Subscribe for More Information
August 12, 2014
09:04 EDTWMTWal-Mart August volatility elevated into Q2 and outlook
Subscribe for More Information
08:37 EDTWMTWal-Mart CEO taking steps to improve business longer-term, says RW Baird
Baird does not expect Wal-Mart's Q2 earnings to be a catalyst for the stock, but the firm believes the company is taking the appropriate steps to grow the business long term. The firm sees a moderation in foreign exchange headwinds and the potential for improving fundamentals across the second half of the year and keep its Outperform rating and $84 price target on the shares.
08:03 EDTWMTGoldman's Retail selections for Q2
Goldman is most above Q2 consensus for Advance Auto Parts (AAP), Best Buy (BBY) and Williams-Sonoma (WSM), sees best risk/reward in Ulta Salon (ULTA) and Sportsman's Warehouse (SPWH), and low visibility in Dick's Sporting (DKS) and Wal-Mart (WMT).
August 11, 2014
10:19 EDTWMTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:37 EDTWMTWal-Mart downgraded to Hold from Buy at Jefferies
Jefferies downgraded its rating on Wal-Mart (WMT) shares to Hold from Buy saying the retailer's investment spending may not be yielding positive results. The firm sees risk to Wal-Mart's annual guidance from elevated expenses and lackluster sales. It dropped its price target for shares to $76 from $89. The stock closed Friday up 72c to $74.67.
August 9, 2014
16:17 EDTWMTChina regulators investigate Wal-Mart store in Shenzhen, Reuters says
Subscribe for More Information
August 8, 2014
09:37 EDTWMTActive equity options trading on open
Subscribe for More Information
August 7, 2014
09:03 EDTBAXBaxter opens biologics facility in Singapore
Baxter International announced the formal opening of its first advanced recombinant biologic facility in Singapore, and expansion plans for a new recombinant protein processing suite. The current suite supports the processing of ADVATE.The second suite will initially process RIXUBIS, a recombinant factor IX protein for the treatment of adults with hemophilia B and, when operational, will be the primary global commercial processing facility. It will also support production of the company’s investigational extended half-life recombinant FVIII treatment BAX 855 upon regulatory approval. The Singapore facility received regulatory approval from the European Medicines Agency in January 2014 for the production of ADVATE2. This allows the facility to process and supply ADVATE to the European Union, Iceland and Norway. The biologics facility in Singapore currently employs more than 400 production staff and expects to reach 450 by 2015 to support the second processing suite.
August 6, 2014
07:55 EDTWMTWal-Mart International chief prioritizing China, Brazil, e-commerce, WSJ reports
Subscribe for More Information
07:47 EDTWMTRetailers pare store openings as shopper visits slide, WSJ says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use